Small Molecule Api Market

Small Molecule API Market: APEJ Projected to be the Most Lucrative Regional Market During the Forecast Period: Global Industry Analysis 2012-2016 & Opportunity Assessment 2017-2027

Global scenario of the small molecule API market – moderate growth rate observed

The global small molecule API market is anticipated to grow at a moderate rate to register a CAGR of 4.9% during the period of forecast, 2017-2027. There are several aspects that govern the growth rate of the global small molecule API market. The key drivers fuelling the growth of the market are factors such as rise in small molecule API growth, the HPAPI witnessing higher boost in growth rate, and the pharmerging countries being explored as alternative sourcing destinations. Trends such as the sourcing of the APIs done from Indian pharmaceutical manufacturers based in the U.S and higher investment in infrastructural facilities in order to raise the in-house production also contribute to the growth of the global small molecule API market. Moreover, owing to these drivers and trends, there are certain opportunities that lurk within the global small molecule API market. To name a few – the growth in healthcare spending in developing nations such as Asia Pacific and other regions and expansion with respect to product offerings as well as reduction in the costs involved.

Asia Pacific excluding Japan to grow at full speed and gain high market share

Asia Pacific excluding Japan (APEJ) reflects higher speed by registering a growth rate of 5.8% during the forecast period 2017 to 2025. The Asian countries hold significant revenue share in the entire market. Most of the anti-inflammatory drugs as well as antibiotic drugs are produced in the Asian counties, with China and India topping the list. Almost 80% of the total antibiotic APIs are produced in China and India and most of these APIs are outsourced to developed regions such as Europe and North America. The main reasons for this to be possible is the abundant availability of raw material needed to produce APIs, and the availability of low cost labour in India and China. Additionally, these regions enjoy a favourable regulatory assistance along with low taxation policies in order to establish API manufacturing businesses. Also, a large patient population consumes non-controlled drugs, which makes Asia Pacific excluding Japan experience a higher in-house API consumption. The APEJ region also reflects a high market attractiveness and higher market share of almost 34% estimated to be held in 2017. This percentage is expected to rise even higher by the end of 2027, following the major trends that push the growth of the global small molecule API market in the APEJ region.

The pharma companies in India had filed DMFs making India the leading country in DMF filing. This infers that in the near future, majority of the API manufacturing contracts from U.S. based companies would be awarded to India based companies. Moreover, the rapid rise in the Indian generics market will also fuel the API market growth in this region.

Trend analysis in the APEJ market – raising the bar of growth in the region

The Asia Pacific excluding Japan region is all set to experience a tremendous growth rate during the forecast period. The APEJ small molecule API market is expected to show a high figure of more than US$ 52 Bn by the end of 2027 and dominate the global market. The main reason for this growth is the high outsourcing in this region. Developing nations of China and India lead by SMEs. The production in these countries is rising owing to limited regulatory coverage. Also, the in-house consumption in India is higher, which has resulted in increased focus on the manufacturing of APIs in India.

The distribution network is also extensive in the overseas markets especially in regions such as Europe, United States and South Africa. Another factor supporting the statement that APEJ is experiencing higher growth is – Indian companies manufacturing APIs are taking advantage of the export opportunities especially in the Latin America region. All these trends are aiding the facts that are favourable for the growth of the small molecule API market in the APEJ region. The region that is the most growing and anticipated to grow even further is China, which shows a higher growth rate to register a CAGR of 6.9% followed by India.

The in-depth and thorough report titled “Small Molecule API Market: Global Industry Analysis 2012-2016 & Opportunity Assessment 2017-2027” gives the reader a feel and flavour of the market understanding with a wide overview of the market thereby supporting decision making and slating different strategies as and when required.

An exhaustive market research report on the small molecule API market offers weighted analysis of the entire market. Focussing on the major segments and covering all factors that have an influence over the market helps predict the growth rate of the market in the particular regions. Below sketched is the market taxonomy that covers all the segments of the global small molecule API market.




Therapeutic Area


  • Standard API

  • High Potency API

  • Captive/In-House

  • Outsourced

  • Clinical

  • Commercial

  • Cardiovascular Diseases

  • Respiratory Disorders

  • Infectious Diseases

  • Metabolic Disorders

  • Oncology

  • Immunology

  • Neurology

  • Urology

  • Dermatology

  • Ophthalmology

  • General Health

  • Others

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • Asia Pacific Excluding Japan

  • Japan

  • Middle East & Africa

 This research study on the small molecule API market delivers value to the reader by making them aware about the past and present scenario of the market. The study also uncovers predictions of the future thereby giving an inkling about the small molecule API market scenario 10 years down the line. It emphasises on the various intelligence acumen such as pricing, product portfolio of various key players present in the market, distribution channel analysis, key developments, trends in present and future, a complete SWOT analysis along with PESTLE analysis and also analysis of the important regions assessed. The study covers revenue generated by API manufacturing including in-house and outsourced manufacturing. The report analyses the demand from in-house production as well as outsourced API production. These insights help plan future decisions and strategic moves that could be easily executed owing to the actionable nature of the understandings present in the report.

An effective research process to ensure maximum proficiency

At Future Market Insights, the analysts follow a rock-solid research process to allow minimum deviations in the research and reach maximum accuracy. In order to get a 3600 view of the market, a strong secondary research is carried out. Assistance of secondary paid sources is just enough to get going in the correct direction. The secondary research gives a direction to the market definition based on which several primary interviews are carried out. Key decision makers from several companies within the market are interviewed as well as opinions of market observers are gathered. The data collected from the secondary sources and the corresponding data gathered by primaries is collated and each data point is verified while conversing with the market experts. The best part of this unique methodology is that the data so gathered undergoes evaluation and validation again and again which makes the intelligence extremely accurate giving a realistic shape to the market scenario. A holistic view of the market thus ensures timely and effective strategies to be implemented owing to the data crunching done with reduced or eliminated deviations from the actual face value of the market.

Competition analysis

The research study provides a separate chapter on the competitive landscape, which covers all the major players in the market, along with their details. Facets such as product portfolio analyses, mergers and acquisitions, developments and innovations, key trends followed, market shares and revenues, geographical spread and expansion plans, marketing strategies and pricing intelligence, etc. of the key players are focussed upon. This helps the reader freeze their own milestones and the various strategic moves required to achieve those milestones. The key players include all the tier companies that have a firm hold over the market and can be said to be the face of the market. The intelligence provided on these players enables the reader to understand the “not-to-do” aspects and how to set foot in the right direction.

The key value additions that the report offers:

  • The entire report gives credible information with an unbiased interpretation, considering all the possible angles and giving it a holistic view
  • The report gives details about each segment present in the market with respect to all important geographies
  • The research study enables unparalleled accuracy owing to the use of a robust research methodology
  • The research on the past and the present scenario in the global market can give actionable insights on the future; a separate dedicated section on the forecasts helps the reader analyse present moves and predict future actions
  • In-depth analysis covers everything giving justice to each segment involved
  • The trends, developments, innovations, restraints and challenges faced by every facet is also covered giving a total briefing about the market and uncovering the possible loop holes